Yuzhen Pan1, Binoy Appukuttan2, Kathleen Mohs1, Liam M Ashander3, Justine R Smith2. 1. Casey Eye Institute, Oregon Health & Science University, Portland, OR, USA. 2. Casey Eye Institute, Oregon Health & Science University, Portland, OR, USA ; Eye & Vision Health, Flinders University, Adelaide, Australia. 3. Eye & Vision Health, Flinders University, Adelaide, Australia.
Abstract
PURPOSE: We aimed: (1) to establish endothelial expression of ubiquitin carboxyl-terminal esterase L1 (UCHL1) in human choroid and retina and; (2) to investigate a role for UCHL1 in basic processes involved in intraocular neovascularization. DESIGN: Controlled translational experimental study. METHODS: Ethanol-fixed human choroid and retina (n = 3 eyes) were indirectly immunostained with rabbit anti-human UCHL1 antibody. Endothelial proliferation and migration assays were performed using cultured human choroidal and retinal endothelial cells (n = 6 isolates/assay). Cells were transfected with UCHL1-targeted or non-targeted small interfering (si)RNA and a commercially available transfection system, and used 48 hours later in experiments. Cell proliferation was evaluated using an assay in which cellular DNA was fluorescently tagged for quantification by microplate reader. Cell migration was examined in an assay that involved counting the number of endothelial cells moving across a perforated membrane. Transcript silencing was verified by Western blot for all assays. RESULTS: Immunohistochemistry confirmed expression of UCHL1 by endothelium in human choroid and retina in vivo. UCHL1-specific knockdown resulted in significantly less proliferation (p < 0.0001) for 3 human choroidal endothelial isolates and 3 human retinal endothelial isolates, and significantly less migration (p ≤ 0.016) for 2 of 3 human choroidal endothelial isolates and 1 of 3 human retinal endothelial isolates. CONCLUSIONS: Our results suggest that UCHL1 may be involved in choroidal and retinal endothelial proliferation in most persons, and endothelial migration in some persons. UCHL1 may be a suitable target for a new treatment of intraocular neovascularisation.
PURPOSE: We aimed: (1) to establish endothelial expression of ubiquitin carboxyl-terminal esterase L1 (UCHL1) in human choroid and retina and; (2) to investigate a role for UCHL1 in basic processes involved in intraocular neovascularization. DESIGN: Controlled translational experimental study. METHODS:Ethanol-fixed human choroid and retina (n = 3 eyes) were indirectly immunostained with rabbit anti-humanUCHL1 antibody. Endothelial proliferation and migration assays were performed using cultured human choroidal and retinal endothelial cells (n = 6 isolates/assay). Cells were transfected with UCHL1-targeted or non-targeted small interfering (si)RNA and a commercially available transfection system, and used 48 hours later in experiments. Cell proliferation was evaluated using an assay in which cellular DNA was fluorescently tagged for quantification by microplate reader. Cell migration was examined in an assay that involved counting the number of endothelial cells moving across a perforated membrane. Transcript silencing was verified by Western blot for all assays. RESULTS: Immunohistochemistry confirmed expression of UCHL1 by endothelium in human choroid and retina in vivo. UCHL1-specific knockdown resulted in significantly less proliferation (p < 0.0001) for 3 human choroidal endothelial isolates and 3 human retinal endothelial isolates, and significantly less migration (p ≤ 0.016) for 2 of 3 human choroidal endothelial isolates and 1 of 3 human retinal endothelial isolates. CONCLUSIONS: Our results suggest that UCHL1 may be involved in choroidal and retinal endothelial proliferation in most persons, and endothelial migration in some persons. UCHL1 may be a suitable target for a new treatment of intraocular neovascularisation.
Authors: Motasem Al-Latayfeh; Paolo S Silva; Jennifer K Sun; Lloyd Paul Aiello Journal: Cold Spring Harb Perspect Med Date: 2012-06 Impact factor: 6.915
Authors: David O Zamora; Michael Riviere; Dongseok Choi; Yuzhen Pan; Stephen R Planck; James T Rosenbaum; Larry L David; Justine R Smith Journal: Mol Vis Date: 2007-10-30 Impact factor: 2.367
Authors: L Bonfanti; P Candeo; M Piccinini; G Carmignoto; M C Comelli; S Ghidella; R Bruno; A Gobetto; A Merighi Journal: J Comp Neurol Date: 1992-08-01 Impact factor: 3.215
Authors: Rupert R A Bourne; Jost B Jonas; Seth R Flaxman; Jill Keeffe; Janet Leasher; Kovin Naidoo; Maurizio B Parodi; Konrad Pesudovs; Holly Price; Richard A White; Tien Y Wong; Serge Resnikoff; Hugh R Taylor Journal: Br J Ophthalmol Date: 2014-03-24 Impact factor: 4.638
Authors: Noor M Ghiasvand; Dellaney D Rudolph; Mohammad Mashayekhi; Joseph A Brzezinski; Daniel Goldman; Tom Glaser Journal: Nat Neurosci Date: 2011-03-27 Impact factor: 24.884
Authors: Feargal J Ryan; Yuefang Ma; Liam M Ashander; Michael Kvopka; Binoy Appukuttan; David J Lynn; Justine R Smith Journal: Transl Vis Sci Technol Date: 2022-08-01 Impact factor: 3.048
Authors: Yun Yun Zhou; Rachel Ka Man Chun; Jian Chao Wang; Bing Zuo; King Kit Li; Thomas Chuen Lam; Quan Liu; Chi-Ho To Journal: Mol Med Rep Date: 2018-05-03 Impact factor: 2.952